EA200000140A1 - METHOD FOR TREATING DIABETES THIAZOLIDINDIONE, A MEANS FOR STRENGTHENING INSULIN SECRETION, AND ALPHA-GLUCOSIDASE INHIBITOR - Google Patents
METHOD FOR TREATING DIABETES THIAZOLIDINDIONE, A MEANS FOR STRENGTHENING INSULIN SECRETION, AND ALPHA-GLUCOSIDASE INHIBITORInfo
- Publication number
- EA200000140A1 EA200000140A1 EA200000140A EA200000140A EA200000140A1 EA 200000140 A1 EA200000140 A1 EA 200000140A1 EA 200000140 A EA200000140 A EA 200000140A EA 200000140 A EA200000140 A EA 200000140A EA 200000140 A1 EA200000140 A1 EA 200000140A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- thiazolidindione
- alpha
- treating diabetes
- insulin secretion
- glucosidase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Описаны способ лечения сахарного диабета и состояний, связанных с сахарным диабетом, у млекопитающего, предусматривающий введение эффективного нетоксичного и фармацевтически приемлемого количества сенсибилизатора инсулина, средства, усиливающего секрецию инсулина, и ингибирующего альфа-глюкозидазу антиги-пергликемического агента млекопитающему, нуждающемуся в этом, и композиция для применения в таком способе.Международная заявка была опубликована вместе с отчетом о международном поиске.A method of treating diabetes mellitus and conditions associated with diabetes mellitus in a mammal is described. for use in this way. The international application was published together with an international search report.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715298A GB9715298D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
PCT/GB1998/002112 WO1999003478A1 (en) | 1997-07-18 | 1998-07-16 | Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200000140A1 true EA200000140A1 (en) | 2000-06-26 |
Family
ID=10816170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200000140A EA200000140A1 (en) | 1997-07-18 | 1998-07-16 | METHOD FOR TREATING DIABETES THIAZOLIDINDIONE, A MEANS FOR STRENGTHENING INSULIN SECRETION, AND ALPHA-GLUCOSIDASE INHIBITOR |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1001784A1 (en) |
JP (1) | JP2001510160A (en) |
KR (1) | KR20010021952A (en) |
CN (1) | CN1263467A (en) |
AP (1) | AP2000001735A0 (en) |
AR (2) | AR016350A1 (en) |
AU (1) | AU8449098A (en) |
BG (1) | BG104062A (en) |
BR (1) | BR9810292A (en) |
CA (1) | CA2297133A1 (en) |
CO (1) | CO4940489A1 (en) |
DZ (1) | DZ2563A1 (en) |
EA (1) | EA200000140A1 (en) |
GB (1) | GB9715298D0 (en) |
HU (1) | HUP0003626A3 (en) |
ID (1) | ID23804A (en) |
IL (1) | IL133907A0 (en) |
MA (1) | MA24608A1 (en) |
NO (1) | NO20000230D0 (en) |
OA (1) | OA11312A (en) |
PE (1) | PE99499A1 (en) |
PL (1) | PL338140A1 (en) |
SK (1) | SK612000A3 (en) |
TR (1) | TR200000133T2 (en) |
UY (1) | UY25101A1 (en) |
WO (1) | WO1999003478A1 (en) |
ZA (1) | ZA986364B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
EP1849475A1 (en) | 1999-06-21 | 2007-10-31 | Eli Lilly & Company | Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes |
DK1741446T3 (en) * | 2000-01-21 | 2008-06-02 | Novartis Pharma Ag | Combinations containing dipeptidyl peptidase IV inhibitors and antidiabetic agents |
WO2001062295A1 (en) * | 2000-02-24 | 2001-08-30 | Takeda Chemical Industries, Ltd. | Drugs containing combined active ingredients |
JP4917712B2 (en) * | 2000-02-24 | 2012-04-18 | 武田薬品工業株式会社 | Concomitant medication |
MXPA03006217A (en) | 2001-01-12 | 2004-10-15 | Sun Pharmaceutical Ind Ltd | Spaced drug delivery system. |
FR2832930A1 (en) * | 2001-12-03 | 2003-06-06 | Lipha | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES |
PT1677792E (en) | 2003-10-31 | 2016-02-09 | Takeda Pharmaceutical | Solid preparation comprising pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester |
CN101103993B (en) * | 2006-07-14 | 2011-03-30 | 北京华安佛医药研究中心有限公司 | Hypoglycemic medicine composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE151634T1 (en) * | 1991-08-26 | 1997-05-15 | Upjohn Co | LIQUID FOOD CONTAINING 3-GUANIDINOPROPIONIC ACID |
US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1997
- 1997-07-18 GB GB9715298A patent/GB9715298D0/en active Pending
-
1998
- 1998-07-15 DZ DZ980173A patent/DZ2563A1/en active
- 1998-07-16 EA EA200000140A patent/EA200000140A1/en unknown
- 1998-07-16 PE PE1998000630A patent/PE99499A1/en not_active Application Discontinuation
- 1998-07-16 AR ARP980103482A patent/AR016350A1/en unknown
- 1998-07-16 WO PCT/GB1998/002112 patent/WO1999003478A1/en not_active Application Discontinuation
- 1998-07-16 IL IL13390798A patent/IL133907A0/en unknown
- 1998-07-16 KR KR1020007000517A patent/KR20010021952A/en not_active Application Discontinuation
- 1998-07-16 CA CA002297133A patent/CA2297133A1/en not_active Abandoned
- 1998-07-16 BR BR9810292-3A patent/BR9810292A/en not_active IP Right Cessation
- 1998-07-16 SK SK61-2000A patent/SK612000A3/en unknown
- 1998-07-16 CN CN98807147A patent/CN1263467A/en active Pending
- 1998-07-16 MA MA25172A patent/MA24608A1/en unknown
- 1998-07-16 JP JP2000502777A patent/JP2001510160A/en active Pending
- 1998-07-16 ID IDW20000077A patent/ID23804A/en unknown
- 1998-07-16 EP EP98935129A patent/EP1001784A1/en not_active Withdrawn
- 1998-07-16 AU AU84490/98A patent/AU8449098A/en not_active Abandoned
- 1998-07-16 HU HU0003626A patent/HUP0003626A3/en unknown
- 1998-07-16 TR TR2000/00133T patent/TR200000133T2/en unknown
- 1998-07-16 PL PL98338140A patent/PL338140A1/en unknown
- 1998-07-17 UY UY25101A patent/UY25101A1/en not_active Application Discontinuation
- 1998-07-17 ZA ZA9806364A patent/ZA986364B/en unknown
- 1998-07-17 CO CO98040749A patent/CO4940489A1/en unknown
-
1999
- 1999-06-28 AR ARP990103110A patent/AR019724A2/en unknown
-
2000
- 2000-01-06 BG BG104062A patent/BG104062A/en unknown
- 2000-01-14 AP APAP/P/2000/001735A patent/AP2000001735A0/en unknown
- 2000-01-17 NO NO20000230A patent/NO20000230D0/en not_active Application Discontinuation
- 2000-01-18 OA OA1200000013A patent/OA11312A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL338140A1 (en) | 2000-09-25 |
SK612000A3 (en) | 2000-07-11 |
AR019724A2 (en) | 2002-03-13 |
HUP0003626A3 (en) | 2001-12-28 |
OA11312A (en) | 2003-10-24 |
MA24608A1 (en) | 1999-04-01 |
JP2001510160A (en) | 2001-07-31 |
DZ2563A1 (en) | 2003-02-15 |
AR016350A1 (en) | 2001-07-04 |
KR20010021952A (en) | 2001-03-15 |
HUP0003626A2 (en) | 2001-05-28 |
PE99499A1 (en) | 1999-12-18 |
TR200000133T2 (en) | 2000-09-21 |
NO20000230L (en) | 2000-01-17 |
CA2297133A1 (en) | 1999-01-28 |
UY25101A1 (en) | 2000-12-29 |
CN1263467A (en) | 2000-08-16 |
IL133907A0 (en) | 2001-04-30 |
GB9715298D0 (en) | 1997-09-24 |
BG104062A (en) | 2000-11-30 |
ZA986364B (en) | 2000-01-17 |
ID23804A (en) | 2000-05-11 |
EP1001784A1 (en) | 2000-05-24 |
WO1999003478A1 (en) | 1999-01-28 |
AP2000001735A0 (en) | 2000-01-16 |
AU8449098A (en) | 1999-02-10 |
BR9810292A (en) | 2000-09-19 |
CO4940489A1 (en) | 2000-07-24 |
NO20000230D0 (en) | 2000-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9700368A2 (en) | Treating of type ii diabetes mellitus with amylin agonists | |
EA199900725A1 (en) | SYNERGETIC COMBINATIONS OF SULFONILM URINE AND GLITAZONE IN THE TREATMENT OF DIABETES | |
EA199800316A1 (en) | SELECTIVE β-ADRENERGIC AGONISTS | |
EA199800857A1 (en) | COMPOSITION FOR REMOVAL OF PAIN AND METHOD OF REMOVAL OF PAIN | |
EA199800667A1 (en) | NEW PHENANTRIDINES | |
EA199900758A1 (en) | SMALL MOLECULES USEFUL AT TREATMENT OF INFLAMMATORY DISEASES | |
EA199800626A1 (en) | APPLICATION OF PPAR-GAMMA AGONIST FOR THE TREATMENT OF SYNDROME X | |
EA200200105A1 (en) | Compounds modulating PPARγ activity; | |
EA200300036A1 (en) | COMBINATION OF DIPEPTIDYLPEPIDIDASE INHIBITORS IV AND OTHER ANTI-DIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS | |
DE122004000049I1 (en) | New insulin derivatives with rapid onset of action. | |
EA199700087A1 (en) | METHOD OF INHIBITING KATEPSIN K | |
DE69009778D1 (en) | USE OF SELECTIVE GABA-B AGONISTS AS AN ANTITUSSIVA. | |
EE9700225A (en) | A method of treating diabetes mellitus using KKF | |
LV12686B (en) | The combination of diabetes treatment with the combination of ap2 inhibitor and its content | |
EA200000140A1 (en) | METHOD FOR TREATING DIABETES THIAZOLIDINDIONE, A MEANS FOR STRENGTHENING INSULIN SECRETION, AND ALPHA-GLUCOSIDASE INHIBITOR | |
NO863342D0 (en) | LOCK REPOLARIZER AND POLARIZATION METHOD, SPECIFICALLY FOR LIGHTED BY AN OPTICAL FIBER. | |
EA200000139A1 (en) | TREATMENT OF DIABETES THIAZOLIDINDIONON, MEANS, INCENTIVE INSULIN SECRETION, AND DIGUANIDE | |
FR2759120B1 (en) | CRYOGENIC PUMP, AND SHIELDING FOR CRYOGENIC PUMP | |
DK0487557T3 (en) | Improving pulp bleaching | |
FI951511A0 (en) | Use of IL-10 for the prevention or treatment of insulin-dependent diabetes mellitus | |
EA200000040A1 (en) | METHOD OF TREATING DIABETES BY THIAZOLIDINDION AND ALPHA-GLUCOSIDASE INHIBITOR | |
EA200000039A1 (en) | TREATMENT OF DIABETES THIAZOLIDINDION AND SULPHONYL URIDE | |
AU6353290A (en) | Portable telephone with power source/mode change during calls | |
EA200000141A1 (en) | METHOD OF TREATMENT OF DIABETAS BY THIAZOLIDINDIONE AND SULFONYL URIDE | |
EA200100501A1 (en) | SURFACE DIAGRAM |